marketwatch.com
U.S. regulators ‘will start moving [booster] recommendations to earlier ages,’
predicts Albert Bourla.
over 2 years ago
marketwatch.com
Calvin Ayre fought battles with the U.S. government. Now he’s backing one of the
most polarizing efforts in the digital currency world.
over 2 years ago
marketwatch.com
Imbruvica seemed invincible in the marketplace. But a new book, “For Blood and Money,” shows how the drug’s creators left a trap door that led to its undoing.
over 1 year ago
marketwatch.com
Follow all the latest U.S. market action for Wednesday here.
about 1 year ago
marketwatch.com
The billionaire investor has beaten the market by betting on Elon Musk. He lands on the MarketWatch 50 list and, in this interview, remains as bullish as ever.
6 months ago
Search by beat, location, outlet & position to find the right journalists for your story.
Sign up for free
